英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
(3S)-3-amino-3-(4-chlorophenyl)propanoic acid |
(S)-3-氨基-3-(4-氯苯基)丙酸 |
131690-60-3 |
詳細(xì)
|
(3S)-3-amino-3-(4-chlorophenyl)propan-1-ol |
(S)-對(duì)氯-Β-苯丙氨醇 |
886061-26-3 |
詳細(xì)
|
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester |
1-Boc-4-(Boc-氨基)哌啶-4-甲酸 |
189321-65-1 |
詳細(xì)
|
(S)-tert-butyl 4-(tert-butoxycarbonylamino)-4-(1-(4-chlorophenyl)-3-hydroxypropylcarbamoyl)piperidine-1-carboxylate |
1143534-57-9 |
1143534-57-9 |
詳細(xì)
|
(S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)piperidine-4-carboxamide |
1143534-59-1 |
1143534-59-1 |
詳細(xì)
|
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine |
6-氯-7-氮雜嘌呤 |
3680-69-1 |
詳細(xì)
|
METHYL 4-((TERT-BUTOXYCARBONYL)AMINO)PIPERIDINE-4-CARBOXYLATE |
4-N-BOC-哌啶-4-甲酸甲酯 |
115655-44-2 |
詳細(xì)
|
(3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one |
(R)-3-甲基-4-(2,4-二甲氧基芐基)哌嗪-2-酮 |
1383146-20-0 |
詳細(xì)
|
3-Methyl-1,2,4-thiadiazole-5-carbohydrazide |
3-甲基-1,2,4-噻二唑-2(3H)-碳酰肼 |
1375066-73-1 |
詳細(xì)
|
(R)-3-METHYLPIPERAZIN-2-ONE |
(R)-3-甲基哌嗪-2-酮 |
922178-61-8 |
詳細(xì)
|
Deucravacitinib |
|
649729-45-3 |
詳細(xì)
|
Deucravacitinib |
4,6-二羥基噠嗪-3-羧酸 |
1442437-21-9 |
詳細(xì)
|
Deucravacitinib |
4,6-二氯噠嗪-3-羧酸鋰水合物 |
2245111-15-1 |
詳細(xì)
|
Elacestrant |
6-芐氧基-3,4-二氫-2H-萘-1-酮 |
32263-70-0 |
詳細(xì)
|
Macitentan |
N-[5-(4-溴苯基)-6-氯-4-嘧啶基]-N'-丙基氨基磺酰胺 |
1393813-42-7 |
詳細(xì)
|
Deucravacitinib |
4,6-二氯噠嗪-3-羧酸乙酯 |
679406-03-2 |
詳細(xì)
|
Infigratinib |
2,6-二氯-3,5-二甲氧基苯胺 |
872509-56-3 |
詳細(xì)
|
Elacestrant |
6-(2-氨基-4-甲氧基苯基)-5,6,7,8-四氫-2-萘酚 |
722520-36-7 |
詳細(xì)
|
Deucravacitinib |
3-(2-甲氧基-3-硝基苯基)-1-甲基-1H-1,2,4-三唑 |
1609394-08-2 |
詳細(xì)
|
Infigratinib |
4-(4-乙基哌嗪-1-基)苯胺 |
115619-01-7 |
詳細(xì)
|
Macitentan |
5-(4-溴苯基)-6-羥基嘧啶-4(1H)-酮 |
706811-25-8 |
詳細(xì)
|
Elacestrant |
2-(4-甲?;交?乙酸 |
34841-47-9 |
詳細(xì)
|
Zavegepant |
3-(7-甲基-1H-吲唑-5-基)-2-氧代丙酸 |
868707-31-7 |
詳細(xì)
|
Infigratinib |
FGFR抑制劑(NVP-BGJ398) |
872511-34-7 |
詳細(xì)
|
Rimegepant |
1-(1-(1H-咪唑酸乙酯-1-羰基)吡啶-4-YL)-1H-咪唑[4,5-B]吡啶-2(3H)-酮 |
1373116-06-3 |
詳細(xì)
|
Infigratinib |
N4-(4-(4-乙基哌嗪-1-基)苯基)-N6-甲基嘧啶-4,6-二胺 |
872511-35-8 |
詳細(xì)
|
Elacestrant |
7-芐氧基-3-溴-1,2-二氫萘 |
722536-73-4 |
詳細(xì)
|
Zavegepant |
3-(哌啶-4-基)-1,2-二氫喹啉-2-酮鹽酸 |
855778-84-6 |
詳細(xì)
|
Elacestrant |
N-(2-(6--羥基-1,2,3,4-四氫萘-2-基)-5-(甲氧基苯基)乙酰胺 |
722520-42-5 |
詳細(xì)
|
Zavegepant |
(2S)-2-氨基-3-(7-甲基-1H-吲唑-5-基)丙酸二鹽酸 |
1414976-15-0 |
詳細(xì)
|
Rimegepant |
(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol |
1373116-05-2 |
詳細(xì)
|
Elacestrant |
2-溴-5-甲氧基苯胺 |
59557-92-5 |
詳細(xì)
|
Deucravacitinib |
BMS-986165 Related Compound 6 |
1609394-23-1 |
詳細(xì)
|
Macitentan |
N-[5-(4-溴苯基)-6-(2-羥基乙氧基)-4-嘧啶基]-N'-丙基氨基磺酰胺 |
1393813-43-8 |
詳細(xì)
|
Elacestrant |
4-甲氧基-2-硝基苯基硼酸 |
860034-09-9 |
詳細(xì)
|
Fezolinetant |
1429560-52-0 |
1429560-52-0 |
詳細(xì)
|
Deucravacitinib |
4,6-二羥基噠嗪-3-甲酸乙酯 |
1352925-63-3 |
詳細(xì)
|
Macitentan |
5-(4-溴苯基)-4,6-二氯嘧啶 |
146533-41-7 |
詳細(xì)
|
Lumateperone |
盧美哌隆雜質(zhì)10 |
313369-16-3 |
詳細(xì)
|
Rimegepant |
(6S,9R)-6-(2,3-二氟苯基)-6,7,8,9-四氫-9-[[三異丙基硅烷基]氧基]-5H-環(huán)庚三烯并[B]吡啶-5-酮 |
1190363-46-2 |
詳細(xì)
|
Ergothioneine |
麥角硫因 |
497-30-3 |
詳細(xì)
|
Ectoine |
依克多因 |
96702-03-3 |
詳細(xì)
|
Spermidine |
亞精胺 |
124-20-9 |
詳細(xì)
|
DIPALMITOYL HYDROXYPROLINE |
二棕櫚酰羥脯氨酸 |
41672-81-5 |
詳細(xì)
|
Sodiumtetrahydrojasmonate |
四氫茉莉酸鈉 |
1175006-92-4 |
詳細(xì)
|
7-methoxy-2,2-dimethylchroman-6-ylpalmitate |
二甲基色滿棕櫚酸酯美白劑 |
1105025-85-1 |
詳細(xì)
|
4-nitroso-1,3-dihydroquinoxalin-2-one |
2(1H)-喹喔啉酮,3,4-二氫-4-亞硝基-(9CI) |
53374-52-0 |
詳細(xì)
|
phenyl N-[(E)-(5-nitrofuran-2-yl)methylideneamino]carbamate |
313369-25-4 |
313369-25-4 |
詳細(xì)
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,9,10-tetrahydro-2-oxo-, ethyl ester |
2-氧代-2,3,9,10-四氫-1H-吡啶[3',4':4,5]吡咯并[1,2,3-DE]喹喔啉-8(7H)-羧酸乙酯 |
313544-31-9 |
詳細(xì)
|
2(1H)-Quinoxalinone,3,4-dihydro-; 1,2,3,4-Tetrahydro-2-quinoxali |
3,4-二氫-1H-喹噁啉-2-酮 |
59564-59-9 |
詳細(xì)
|
Calcifediol |
25-羥基維生素D3 |
19356-17-3 |
詳細(xì)
|
Fisetin |
漆黃素 |
528-48-3 |
詳細(xì)
|
Anserine |
鵝肌肽 |
584-85-0 |
詳細(xì)
|
Cholesterol |
植物源膽固醇 |
57-88-5 |
詳細(xì)
|
DIAMINOPYRIMIDINE OXIDE |
二氨基嘧啶氧化物 |
|
詳細(xì)
|
Omaveloxolone (RTA 408) |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
詳細(xì)
|
N-Carbethoxy-4-piperidone |
N-乙氧羰基-4-哌啶酮 |
29976-53-2 |
詳細(xì)
|
(2S)-Hydroxy(phenyl)acetic acid-(4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (1:1) |
(2S)-2-羥基-2-苯基乙酸;(4aS,9bR)-6-溴-1H,2H,3H,4H,4aH,5H,9bH-吡啶[4,3-b]吲哚 |
1059630-13-5 |
詳細(xì)
|
Deucravacitinib |
2-甲氧基-3-硝基苯甲酸甲酯 |
90564-26-4 |
詳細(xì)
|
Deucravacitinib |
2-甲氧基-3-硝基苯甲酰胺 |
722538-98-9 |
詳細(xì)
|
Deucravacitinib |
3-(2-甲氧基-3-硝基苯基)-1H-1,2,4-三唑 |
1609394-05-9 |
詳細(xì)
|
Deucravacitinib |
2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺 |
1609394-10-6 |
詳細(xì)
|
Deucravacitinib |
4,6-二氯-N-(甲基-d3)-3-噠嗪甲酰胺 |
1609393-89-6 |
詳細(xì)
|
Deucravacitinib |
環(huán)丙酰胺 |
6228-73-5 |
詳細(xì)
|
6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride |
6-溴-2,3,4,5-四氫-1H-吡啶并[4,3-B]吲哚鹽酸鹽 |
1059630-11-3 |
詳細(xì)
|
(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate |
(6bR,10aS)-3-甲基-2,3,6b,7,10,10a-六氫-1H-吡啶并[3',4':4,5]吡咯并[1,2,3-de]喹喔啉-8(9H)-羧酸叔丁酯 |
313369-26-5 |
詳細(xì)
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-3-methyl-, (6bR,10aS) |
(6BR,10AS)-3-甲基2,3,6B,7,8,9,10,10A八氫-1H-吡啶并[3' ,4' :4,5]吡咯并[1,2,3- DE]喹喔 |
313368-85-3 |
詳細(xì)
|
4-Chloro-p-fluorobutyrophenone |
4-氯-4'-氟苯丁酮 |
3874-54-2 |
詳細(xì)
|